CAH's Q3 results are likely to benefit from strong specialty momentum and GMPD progress, but tougher comps and tariff ...

Every weekday, the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. ET. Here's a recap ...

Nvidia shares popped to an all-time high on Monday – its first since last October – but the chip giant's performance has been ...

Robinhood says phishing emails from noreply@robinhood.com abused its account creation flow, with customers urged to delete them.

Options traders are heavily bullish ahead of the event. The security's 50-day call/put volume ratio of 3.45 at the ...

Short sellers' bets against U.S. life insurance stocks more than doubled in ⁠the ⁠past year to over $5 billion, a Reuters ...

Kimberly-Clark stock yields 5.20% with a long dividend history, but stagnant growth, a high payout ratio and a pricey Kenvue ...

Compass Therapeutics shed half its stock price this morning as investors digested its bispecific antibody’s failure to hit an ...

TM maintains industry-leading operating margins and resilient revenue growth but faces tariff impacts and geopolitical risks.

The race for national AI strategy dominance has moved well beyond theoretical frameworks. Governments across Asia, the Middle ...

Investing.com -- Compass Therapeutics, Inc. (NASDAQ:CMPX) shares fell 80% Monday after the company announced results from its COMPANION-002 Phase 2/3 study of tovecimig in biliary tract cancer ...

The Dow Jones index falls Monday. Google parent Alphabet clears an entry on the stock market today. Microsoft rises after a ...